Skip to main content

Table 1 Classification of 96 ovarian cancer patients regarding their analyzability for the study

From: Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)

Number Analyzability Explanation
52 Analyzable Patients received a traceable chemotherapy and the used drugs were analyzed by the CTR-Test
44 Not analyzable Patients either did not receive a chemotherapy (12), drugs were used that were not measured in the CTR-Test (17), the CTR-Test did not yield a result (11) or no record about chemotherapy or response is available (4)